Goldman Sachs
NVAX icon

Goldman Sachs’s Novavax NVAX Stock Holding History

Goldman Sachs’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53M Sell
187,400
-8,900
-5% -$80.7K ﹤0.01% 4766
2025
Q4 		$1.32M Buy
196,300
+8,900
+5% +$67.1K ﹤0.01% 4920
2025
Q3 		$1.62M Hold
187,400
– – ﹤0.01% 4660
2025
Q2 		$1.18M Buy
+187,400
New +$1.24M ﹤0.01% 4573
2024
Q3 		– Sell
-1,330,700
Closed -$16.8M – 5998
2024
Q2 		$16.8M Buy
+1,330,700
New +$13.4M ﹤0.01% 2028
2023
Q2 		– Sell
-491,700
Closed -$3.41M – 5966
2023
Q1 		$3.41M Buy
491,700
+441,600
+881% +$4.06M ﹤0.01% 3411
2022
Q4 		$515K Sell
50,100
-228,700
-82% -$4.04M ﹤0.01% 4845
2022
Q3 		$5.07M Buy
278,800
+177,300
+175% +$7.68M ﹤0.01% 3124
2022
Q2 		$5.22M Buy
+101,500
New +$5.26M ﹤0.01% 3090
2022
Q1 		– Sell
-178,900
Closed -$25.6M – 6810
2021
Q4 		$25.6M Buy
+178,900
New +$30.7M 0.01% 1903
2021
Q1 		– Sell
-2,000
Closed -$223K – 6260
2020
Q4 		$223K Sell
2,000
-15,700
-89% -$1.67M ﹤0.01% 5038
2020
Q3 		$1.92M Buy
+17,700
New +$2.16M ﹤0.01% 3596
2016
Q4 		– Sell
-1,000
Closed -$42K – 7021
2016
Q3 		$42K Buy
+1,000
New +$129K ﹤0.01% 6544
2016
Q2 		– Sell
-5,230
Closed -$540K – 7174
2016
Q1 		$540K Hold
5,230
– – ﹤0.01% 4675
2015
Q4 		$878K Sell
5,230
-2,650
-34% -$408K ﹤0.01% 4425
2015
Q3 		$1.11M Buy
+7,880
New +$1.77M ﹤0.01% 4369

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's NVAX Position: Q1 2026 in Review

Goldman Sachs increased its Novavax (NVAX) stake by 29% in Q1 2026, buying an estimated $2.89M and bringing the position to 1,409,446 shares worth $11.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2951.

Goldman Sachs first reported a position in NVAX in Q2 2013 and has held it in 52 quarters since. The position peaked at $139M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Goldman Sachs held 1,409,446 shares of Novavax worth $11.5M as of Q1 2026.
  • Goldman Sachs bought 318,887 Novavax shares in Q1 2026, an estimated $2.89M.
  • Novavax made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2951 holding.
  • Goldman Sachs first reported a position in Novavax in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Novavax position peaked at $139M in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.